We shared our latest advancements in base editing, DMD, and AAV vector design. Our presentations covered a range of cutting-edge research topics:
1. Drug metabolism and pharmacokinetics in mice systemically administrated with a base editing drug for Duchenne Muscular Dystrophin (DMD)
2. A transformative DMD cytosine base editing drug
3. Therapeutic exon skipping through cytidine base editing in DMD mice model
4. Potency and off-target evaluation of DMD base editing medicine in vitro
5. A Novel AAV Vector Design for Reducing Cross-Packaged ITR Promoter Activity
6. Expanding Base Editor Scope with Embedding Strategy
We are eager to showcase our innovative work at this prestigious event!
Stay tuned for updates.
